Pharmacy Podcast Network

  Today's guest on the podcast shares how to proactively preserve both one's health span and “beauty span”: the visible vitality, confidence, and connection to self over time. We got into some juicy and controversial topics around aging and the beauty industry, as well sustainability. My guest asserts that aging is not a passive process, it is something we can actively manage. Her mission is to help people understand that beauty, energy, and longevity are interconnected. When you support the body at a cellular and hormonal level, you don't just look better, you function better. Dr. Sofia Din is a board-certified Family Physician with over 25 years of medical experience and advanced training in Geriatrics. She began her career in hospital medicine and long-term care, where she served as a Medical Director, before shifting her focus from disease management to proactive longevity and anti-aging medicine. She is the Medical Director of Juvanni Medical P.C. in Westchester, New York, where she integrates aesthetics, hormonal health, and advanced non-surgical technologies to help patients navigate menopause, andropause, metabolic slowdown, and chronic skin failure. Dr. Din is also the author of Do We Really Need Botox? and the host of the podcast Bathroom Diaries, where she explores the science, psychology, and cultural dimensions of aging, beauty, and self-perception. Connect with Sofia via: — Juvanni Med Spa: Email: juvannimedspa@gmail.com  Website: Botox Guru at Juvanni Med Spa FB: Juvanni Med Spa IG: @drjuvanni YT: @DrJuvanni Twitter/X: @JuvanniMedSpa Linked In: Juvanni Medical — Dr. Sofia Din: FB: Sofia Din IG: @therealdrjuvanni YT: @DrJuvanni TikTok: @botoxguru Linked In: Sofia Din Podcast (Spotify): Bathroom Diaries w. Dr. Sofia Din — Minerva Life: YT: @minervalife6529 TikTok: @sofiadinmd Visit https://marinabuksov.com for more holistic content.  Music from https://www.purple-planet.com.  Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Sponsored by Rx4Route This Week in Pharmacy returns with a timely two-part episode focused on pharmacy operations, medication access, and the growing responsibility of healthcare communicators in the age of AI. In our first segment, we welcome Joseph Dymowski, PharmD, CEO of Centennial Pharmacy Services, and Doniyor Sattarov, Vice President of Operations at Rx4Route, for a conversation about expanding long-term care pharmacy at home. As more patients age in place, pharmacies must rethink delivery, logistics, documentation, and patient communication as essential parts of care. Delivery is no longer just a convenience. It is a critical extension of pharmacy services. Reliable routing, real-time tracking, and proof of delivery help pharmacies improve adherence, reduce operational friction, and build stronger trust with patients, caregivers, and providers. Expanding LTC pharmacy-at-home services, building scalable delivery workflows, improving route efficiency, using delivery technology to support compliance, and why logistics may become a major competitive advantage for pharmacies. This episode is sponsored by Rx4Route, pharmacy delivery software designed to help pharmacies streamline delivery operations, optimize routes, track orders, and improve proof-of-delivery workflows. In our second segment, we speak with **Vincent Grippi, CEO of Grippi Media, about the dangers of AI-generated misinformation and the higher standard required in healthcare communications. As AI becomes more common in content creation, communications professionals must protect accuracy, credibility, and patient trust. In healthcare, misinformation can influence clinical understanding, damage reputations, and create confusion across the industry. That is why content for healthcare professionals must be reviewed, verified, and guided by human judgment. AI misinformation in healthcare, responsible content development, source verification, editorial review, subject-matter expertise, and how communicators can use AI without sacrificing trust. This episode connects two critical forms of trust in pharmacy: operational trust at the patient's door and informational trust across every communication channel. Featured Guests: Joseph Dymowski, PharmD— CEO, Centennial Pharmacy Services Doniyor Sattarov— Vice President of Operations, Rx4Route Vincent Grippi— CEO, Grippi Media

This episode we look at a bunch of statements from the FDA and from HHS Secretary Robert F. Kennedy, Jr. And of course there are peptides to talk about these days. Does anyone really know what's going on with those? Our deep dive is a special one: Our guest is Al Carter, the CEO of the National Association of Boards of Pharmacy, and he gives us a totally different perspective on the regulatory landscape at the level that affects pharmacists every day. Links from the podcast: The latest FDA statement on DTE: https://fllw.me/4sL6zXw  The Coalition for Compounding Excellence's first audit process guide (compounding records and quality control): https://fllw.me/3Oew1qr  FDA Law Blog on the state of peptide compounding: https://fllw.me/4cpFF2C  National Association of Boards of Pharmacy: https://nabp.pharmacy  Join APC! https://a4pc.org/join 

On this episode of the Cardinal Health™ Counter Talk™ Podcast, host Jason Callori explores the benefits of co-branding your pharmacy with the Medicine Shoppe International, Inc. (MSI) franchise. The episode features Tony Ibrahim, a multi-store owner with the Medicine Shoppe® Pharmacy network, and Lance Mindt, a MSI Franchise Business Consultant.   Tony and Lance discuss how pharmacies can benefit from co-branding their stores while maintaining their local brand identity through the co-branding model. Learn how independent pharmacies can preserve their local identity, streamline operations and foster growth while gaining the support and expertise of a national franchise.   Click here to learn more about co-branding. 

Welcome back to PPN – The Precision Medicine Pharmacist. In part one of our series, Precision Psychiatry in Practice – A Pharmacist–Physician Collaboration, we explored how a collaborative approach can begin to reshape psychiatric care — building trust, aligning perspectives, and creating space for more personalized treatment. Today, we move deeper into what that looks like in real-world, integrative medicine psychiatry. I'm excited to welcome back Dr. Saba Arshad, joined by Dr. Afshan Khan, as we explore how their partnership brings together different clinical perspectives to care for the whole patient — not just symptoms, but the broader context of mental health, lifestyle, and individualized needs. In this episode, Precision in Practice: Real Stories, Real Results in Integrative Psychiatry, we focus on the human side of collaboration. How do two clinicians with different training and strengths come together to approach complex cases? What does shared decision-making really look like in practice? And how does this integrative model shape better patient outcomes? We'll walk through real patient cases, explore the dynamics of their collaboration, and uncover how this partnership continues to evolve to meet patients where they are. If part one introduced the foundation, today's episode brings that collaboration to life. Let's dive in.

AI in healthcare is no longer a futuristic concept. It's already answering the phones at your local CVS. We're pulling back the curtain on how AI is currently being used in pharmacy practice, from encrypted "VA GPT" systems for note-writing to controversial new phone bots that some patients claim are a "stain on society". We dive into the big news of the CVS and Google Cloud partnership to launch Health100, a platform designed to integrate your refills, copays, and even wearable health data into a single AI-driven hub. While the promise of centralized care sounds like a dream, the "real-world" experience can feel like a nightmare. We react to a brutal Reddit thread and even call a CVS live to demonstrate the frustration of wrestling with a robot that refuses to transfer you to a human. Whether you're a "tinfoil hat" wearer worried about data leaks or someone just trying to get a prescription after surgery, you need to hear the clinical and personal reality of the AI takeover. This show is intended for educational and informational purposes.

Congratulations to Logan Eury and his new wife Emily, got married today, May 1, 2026!  This C.O. Bigelow Collab Introduces the 188-Year-Old Pharmacy to a New Generation Abbode is taking over the Carolyn Bessette-Kennedy-approved shop for a month-long pop-up. https://fashionista.com/2026/05/co-bigelow-abbode-pop-up-carolyn-bessette-impact  The article highlights how a pop-up and renewed interest in C.O. Bigelow has been fueled by the cultural resurgence of Carolyn Bessette-Kennedy's minimalist style, amplified by media and social buzz. This renewed attention has driven significant foot traffic and sales, showing how storytelling, nostalgia, and “quiet luxury” aesthetics can translate into real retail impact.   Q&A: Mayo Clinic leaders share strategies for managing high-cost drugs without breaking the bank | Asembia AXS26 Summit https://www.managedhealthcareexecutive.com/view/q-a-mayo-clinic-leaders-share-strategies-for-managing-high-cost-drugs-without-breaking-the-bank-asembia-axs26-summit Mayo Clinic leaders emphasize that managing high-cost drugs requires clear definitions, structured formulary review processes, and multidisciplinary collaboration to balance cost, access, and clinical value. They highlight the importance of evaluating safety, efficacy, financial impact, and site-of-care decisions together, while noting that non-340B systems face increasing pressure from rising costs and reimbursement constraints. Ultimately, success depends on stronger alignment between health systems, manufacturers, and payers to sustain access without compromising quality of care.  Where Gross-to-net Pressure Actually Lives After Launch Today's guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx. https://www.drugchannels.net/2026/05/where-gross-to-net-pressure-actually.html The article explains that “gross-to-net pressure” isn't driven by a single factor, but by a combination of rebates, discounts, fees, and policy changes that continue to reshape how drug pricing actually works behind the scenes. As the industry shifts toward a “net pricing” model, traditional rebate-driven strategies are weakening, forcing manufacturers, PBMs, and pharmacies to rethink how value and profits are generated. Today's featured guest is Dr. Ndidiamaka Okpareke PharmD for Congress Dr. Ndidiamaka “Didi” Okpareke, PharmD, is a pharmacist, entrepreneur, and political candidate running for Congress in New Mexico's 1st Congressional District. A first-generation Nigerian-American, she built her career in healthcare after graduating from the University of New Mexico College of Pharmacy and went on to found and lead a successful compounding pharmacy serving her community.  Motivated by nearly two decades of patient care experience, Okpareke entered the political arena to address challenges such as healthcare access, rising costs, and the shortage of providers in New Mexico. Running as a Republican, she emphasizes strengthening healthcare systems, supporting economic growth, and preserving opportunity for future generations, positioning herself as a community-focused leader bringing frontline healthcare insight into public policy.  This special episode highlights how TJM Labs is redefining pharmacy operations through AI-driven automation, bringing together insights from industry leaders Bhavesh Patel, PharmD—CEO of Carepoint Pharmacy—and Jonathan Adly, PharmD, MBA—CEO of TJM Labs. At the center of the conversation is how modern pharmacies are facing rising prescription volumes, staffing constraints, and increasing operational complexity, and why traditional manual workflows can no longer keep pace. TJM Labs addresses this challenge by deploying AI-powered “digital workers” that automate tasks like prescription intake, data entry, and patient communication—allowing pharmacy teams to shift their focus back to patient care and clinical decision-making.  Through the lens of both operator and innovator, the discussion explores how AI is not replacing pharmacy professionals, but augmenting them—reducing burnout, improving accuracy, and enabling scalable growth. With automation handling up to the majority of repetitive workload and delivering measurable ROI, TJM Labs represents a new model where technology and pharmacy expertise work together to create more efficient, patient-centered operations. 

Tennessee lawmakers have passed a major pharmacy reform bill aimed at pharmacy benefit managers, or PBMs, by barring companies from owning both a PBM and a pharmacy. The legislation is widely seen as targeting CVS Health, which owns Caremark and operates pharmacies across the state. Supporters say the bill is designed to curb vertical integration, restore fair competition, and protect independent pharmacies from reimbursement practices they view as harmful to patient access and community pharmacy survival. CVS has pushed back hard, warning that the new law could force it to shut down its 134 Tennessee pharmacy locations and trigger a legal challenge. The company argues the measure would reduce access for patients and does not directly address broader PBM issues like pricing or formularies. This Tennessee fight reflects a larger national battle over PBM reform, pharmacy ownership, market power, and the future of prescription drug access.  

Clinical Pearls, Pain Pod edition: Pain Pearls Part 2 (of many) with Dr. Sing Ping Chow, PharmD as we discuss methadone, buprenorphine, gabapentin, pain pharmacists, AI, and beyond! A cornucopia of pain conundrums and potential solutions and/or tools to help mitigate. All here, nicely packaged, randomly, in one episode of the Pain Pod! One of many more to come, in a miniseries titled: “Pain Pearls”, only here on the Pain Pod! Come one, come all, to the Pain Pod!!! P.S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us or LinkedIn to directly reach Mark and have your voice heard!  

What does it actually mean to be healthy if your labs come back "normal" but you still feel terrible? For too many high-achieving professionals, that question goes unanswered for years. Today's guest knows that experience firsthand and has built her entire practice around closing that gap. Ekat is a Nutritional Therapy Practitioner (NTP), Restorative Wellness Practitioner (RWP), and Board-Certified Integrative Nutrition Health Coach. After 16+ years on Wall Street, she experienced firsthand what chronic stress, long hours, and burnout can do to a body, and what conventional medicine often misses when it does.  Through her virtual practice, Healthfully Ekat, she helps busy, high-achieving women uncover the root causes behind persistent digestive issues, hormonal imbalances, and chronic fatigue using functional lab testing, personalized nutrition, and holistic lifestyle strategies. Her message is as straightforward as it is powerful: you're only going to be as successful as your health allows you to be. In this episode, we talk about what it really takes to stop guessing and start understanding what your body actually needs, so your energy, gut, and hormones can work for you instead of against you. In this episode, we cover: • Why "normal" labs don't always mean optimal health • The connection between chronic stress, gut health, and hormonal chaos • How functional lab testing changes the root cause conversation • The microbes we often ignore but shouldn't (including parasites!) • What high-performing professionals consistently get wrong about their health • Why true success requires your body to keep up with your ambition Connect with Healthfully Ekat via: Email: healthfullyekat@gmail.com  Website: https://www.healthfullyekat.com/  IG: @healthfully.ekat Visit https://marinabuksov.com for more holistic content.  Music from https://www.purple-planet.com.  Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Guests: Gil Bashe Chair Global Health and Purpose at FINN Partners Maya Hajizada Chief Revenue Officer at Rx2Go C. Daniel Mullins Professor at University of Maryland School of Pharmacy Mina G Yacoub PharmD BCPS Founder & CEO at Qik Productions

This is the Pharmacy Profit Summit Live Recap Show! Welcome to Part Two. Pharmacy owners from across the US have come together to learn ways to improve their pharmacy's profit and bring better value to their patient's. The Pharmacy Podcast Network brings you this exclusive "man on the street" coverage of the show with interviews hosted by Todd Eury talking to the attendees, speakers, and vendors. In this episode, we hear interviews with: Pete Nagel - CurifyLabs Christopher Flores - Payment Processing Doug Soupon - RxOneShop Fiona Sartoretto Verna Omar - Utopia Pharmacy  

“My doctor says it's safe, but Google says it's not… what do I do?” It's the reality so many pregnant and breastfeeding moms face when they're given conflicting medication advice.  In this episode, consulting pharmacist Dr. Danielle Plummer and clinical pharmacist Dr. Tara Birch pull back the curtain on pregnancy medication confusion and why it happens. As Tara puts it, “Pharmacists need to be utilized more than they are. We are medication specialists.”  The core message is clear: every mom needs a pharmacist as part of her care team. From preconception through the postpartum period, pharmacists bring the medication expertise that is often missing and can prevent confusion, errors, and unnecessary risk. From the overwhelm of choosing a prenatal vitamin to navigating mixed messages from providers and “Dr. Google,” they walk through what's actually happening behind the scenes and how to make safer, more confident decisions. You'll hear why “there is no one-size-fits-all prenatal vitamin,” how postpartum needs can increase during breastfeeding, and why a truly collaborative care team leads to better outcomes for both mom and baby. If you've ever second-guessed a medication, felt confused by conflicting advice, or wished you had a clear, trusted voice guiding you, this conversation will change how you approach your care. What You'll Learn: - Why pharmacists are underused in maternal care - How to handle conflicting medication advice - How to choose the right prenatal vitamin - Why postpartum nutrition matters - The risks of relying on Google or AI for medication decisions - How collaborative care improves outcomes Expert Insights: - Pharmacists in Maternal Care: Pharmacists are medication experts but are often excluded from care teams. Including them improves safety and outcomes. - Conflicting Advice: Patients often receive mixed guidance from providers. Pharmacists help clarify evidence-based decisions. - Prenatal Vitamins: Not one-size-fits-all. Needs vary by diet, genetics, and symptoms. - Postpartum Nutrition: Nutrient needs may increase after delivery, especially during breastfeeding. - Gaps in Care: Hospital care is collaborative. Outpatient care is fragmented, creating safety risks. - Preconception Planning: Medication review before pregnancy can prevent first-trimester risks. Connect with Dr. Tara Birch: https://themotherbabypharmacist.com www.instagram.com/themotherbabypharmacist/ Phone/Text: 321-609-5424 Connect with Dr. Danielle Plummer: www.HGPharmacist.com linkedin.com/in/daniellerplummer

In this episode, we explore YARAL Pharma's latest move to expand patient access to prescription topical patches through a new collaboration with UpScriptHealth. The partnership brings YARAL's prescription topical treatments to a direct-to-consumer telehealth platform, giving patients a way to consult with licensed clinicians online and, when appropriate, receive prescriptions through participating pharmacies. The announcement reflects a broader shift in how pharmaceutical manufacturers are using digital health channels to improve convenience, affordability, and access to care.  We also examine what this means for the evolving pharmacy and telehealth landscape. YARAL Pharma said the collaboration supports its focus on continuity of supply, quality, customer service, and broader access to generic medicines, while UpScriptHealth highlighted its long-standing role in direct-to-patient telehealth services and its history of helping patients access care and prescriptions through online channels.  What You'll Learn in This Episode: YARAL Pharma's prescription topical patches are now available through UpScriptHealth's telehealth platform. Patients can use the platform to connect with licensed healthcare providers virtually, determine eligibility, and potentially receive a prescription fulfilled through participating pharmacies. YARAL described the collaboration as part of its effort to expand access to affordable generic medicines through digital channels.  The episode also highlights the companies behind the announcement. YARAL Pharma is the U.S. generics subsidiary of IBSA, and UpScriptHealth describes itself as a direct-to-patient telehealth company that has helped facilitate more than two million prescriptions and works with a network of hundreds of physicians.  Key Discussion Points:  YARAL Pharma's prescription topical patches are now offered through UpScriptHealth's telehealth platform.   The partnership creates a direct-to-consumer path for online consultation and prescribing, when clinically appropriate.   YARAL says the move strengthens patient convenience and supports access to affordable generic treatment options.   UpScriptHealth brings an established national telehealth network and direct-to-patient infrastructure to the collaboration.   The announcement signals continued momentum in telehealth-enabled prescription access and digital pharmaceutical distribution. This last point is an inference based on the stated goals and structure of the partnership. 

Welcome to the Pharmacy Podcast Network's special 3-Part series on the coverage of the American Pharmacist Association's Annual Conference event held in Los Angeles, California on March 27-31st. In this series, you'll hear from 4 key social media influencers having a massive impact on Pharmacy Advocacy, innovators exploring the advancing technology and use of AI in Pharmacy, and more! In this episode, we hear from: Stephen Beckman - Yaral Pharma Kati Forbes, PharmD Robbie Abasi, PharmD, Xavier Hill, PharmD, and Sam Llona, PharmD - RxRated Podcast Katlyn - Student at University of Montanna Sakhi Gaurang Patel - CuraVoice   Thank you to Yaral Pharma and the Independent Pharmacy Cooperative (IPC) for sponsoring this episode!  

TWIRx News: The FDA plans to remove 12 peptide bulk drug substances from Category 2 of the Section 503A compounding list after their nominations were withdrawn. For compounders, the key issue is that this change does not automatically make compounding these substances permissible, leaving pharmacies exposed to ongoing regulatory uncertainty until the FDA makes further decisions. A nationwide Class II recall has been issued for Xanax XR 3 mg tablets in 60-count bottles, lot 8177156, after the product failed dissolution testing. Pharmacists should immediately locate and quarantine affected stock while reminding patients not to stop benzodiazepine therapy suddenly without direction from a healthcare provider. Community pharmacies are taking on a larger role in wound care by serving as an accessible first point of contact for patients with minor injuries. Pharmacists can help assess wounds, recommend appropriate over-the-counter treatment, watch for warning signs of complications, and refer patients for higher-level care when needed. Special sponsor interview with Allison Arant with Clearway Health.  Featured interview with  the World's Leading Innovation Theorist John Nosta Guests & sponsors of today's TWIRx, Perigon 360 Pharmacy with Chris Antypas PharmD and ed Mills  And a bonus interview with Dr. Andy Krut PharmD, on Psychedelics (e.g., LSD, psilocybin, DMT)

This is the Pharmacy Profit Summit Live Recap Show! Welcome to Part One. Pharmacy owners from across the US have come together to learn ways to improve their pharmacy's profit and bring better value to their patient's. The Pharmacy Podcast Network brings you this exclusive "man on the street" coverage of the show with interviews hosted by Todd Eury talking to the attendees, speakers, and vendors. In this episode, we hear interviews with: Ross Miller - TJM Labs Bradly Davie - InBody Jonathan Tanner - BreathRox Ajay Mehra - UGO Rx Amanda Pritchett - Vaccine Connect

Welcome to the Pharmacy Podcast Network's special 3-Part series on the coverage of the American Pharmacist Association's Annual Conference event held in Los Angeles, California on March 27-31st. In this series, you'll hear from 4 key social media influencers having a massive impact on Pharmacy Advocacy, innovators exploring the advancing technology and use of AI in Pharmacy, and more! In this episode, we hear from: Kelli Stovall, RPh, EMBA, - IPC Amantha Bagdon - RxPost Dixie Leikach - PeerRx Dr Erin Parsons, PharmD - LSPedia Sally Rafie, PharmD Thank you to Independent Pharmacy Cooperative (IPC) for sponsoring this episode!

This Week in Pharmacy – 04-06-2026 Sponsored by Outcomes and Independent Pharmacy Cooperative (IPC) On this episode of This Week in Pharmacy, we dig into another high-impact week across the profession with TWIRx news, practice transformation, oncology leadership, pediatric research innovation, and a look ahead to one of specialty pharmacy's biggest gatherings of the year. This week's episode is powered by our sponsors, Outcomes and Independent Pharmacy Cooperative (IPC), organizations continuing to support independent pharmacy innovation, patient engagement, and pharmacy performance. In the TWIRx News segment, we cover four important stories shaping the national conversation in pharmacy. First, we discuss the federal fraud case involving a Dearborn Heights pharmacy owner who pleaded guilty in a $1.9 million health care fraud scheme. According to the U.S. Department of Justice, Rabih Hamdan admitted to conspiring to submit false claims for prescription drugs that were either medically unnecessary or never actually dispensed, impacting Medicare, Medicaid, and Blue Cross Blue Shield of Michigan. Federal prosecutors say the fraudulent claims totaled at least $1.9 million over a five-year period. Next, we look at oncology pharmacy leadership through the lens of Amy Seung, who is stepping into the HOPA presidency during a period of rapid acceleration in cancer care. In Pharmacy Times, Seung describes a practice environment where new approvals, indications, toxicity data, and clinical questions are arriving weekly or even daily. She positions HOPA as a key bridge between emerging science and real-world implementation, with this year's conference emphasizing bispecific therapies, real-world evidence, supportive care, and toxicity management. We also spotlight a powerful research update from the UNC Eshelman School of Pharmacy, where professor David Drewry and student researchers are advancing work on diffuse intrinsic pontine glioma (DIPG), an aggressive pediatric brain cancer with limited treatment options and an average life expectancy of about one year after diagnosis. The team is using an open-science model to accelerate discovery while keeping future therapies more affordable, and they are working with M4K Pharma to advance an ALK2 inhibitor toward a Phase 1 clinical trial. Finally, we feature a practice transformation story from Drug Topics: Gregg Jones, MBA, RPh, made the leap from corporate pharmacy leadership to launching Compass Core Pharmacy, described as Rhode Island's first cost-plus pharmacy model. The cash-only model focuses on generics, uses AI-driven ordering, serves a growing veterinary segment with more than 1,400 pet prescriptions, and operates as a CLIA-waived pharmacy offering point-of-care testing. It is a compelling example of how pharmacists are reengineering care delivery outside the traditional reimbursement framework. We are also getting ready for Asembia 2026 in Las Vegas, where the Pharmacy Podcast Network will once again provide press coverage with support from Clearway Health. You can find us at booth 1805, where we'll be capturing conversations that matter across specialty pharmacy, access, patient support, innovation, and care delivery. Our first featured interview is with Nick Baird, Director of Marketing with Outcomes, where we will explore the growing role of pharmacy engagement, patient activation, and value creation in community-based care. Our second interview features Dr. Jen Hammons, PharmD, DrPH, with Health Wagon, a vital community healthcare organization dedicated to serving medically underserved patients through an expanding network of care. In 2024 alone, Health Wagon served 7,291 unique patients through 21,615 patient encounters, supported by five mobile health units, three stationary clinic sites, a dental clinic, a vision clinic, and a pharmacy. Known for hosting one of the nation's largest health outreach efforts of its kind, Health Wagon continues to expand its impact through the dedication of staff, volunteers, trustees, partners, donors, and supporters. Join us as we connect the week's top headlines to the broader transformation underway in pharmacy practice, policy, specialty care, and community health. To learn more, follow the Pharmacy Podcast Network and stay connected as we head into Asembia 2026.

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Linda Clark and Brad Gallagher, Co-Leaders of Barclay Damon's Health Care Controversies and Pharmacy Teams. They explore the rapidly evolving Pharmacy Benefit Manager (PBM) regulatory landscape and its impact on specialty pharmacies, offering key considerations for contracting and strategies to strengthen audit readiness and compliance. Linda and Brad also share practical guidance to help specialty pharmacies increasingly under pressure to manage their risk and position themselves for long-term success.

Independent pharmacists are facing increasing demands, and outdated payment processes add unnecessary friction. In this episode, Jason Callori speaks with Halston Prox, Founder and CEO of Tabz (formerly HealNow), and Cardinal Health Solution Manager Natalie Girardi about how modern payment technology is transforming independent pharmacies. The conversation highlights how Tabz helps streamline workflows, reduce payment friction, and enable faster compensation for pharmacists.

Today's episode is one for the books! Seriously, if there's one conversation you choose to listen to in my body of work, this is the one. My beautiful guest and I went deep into holistic healing in the truest sense of that term, through the lens of systems level change. We talked about what it takes to repair connection within ourselves, with one another, and with the more-than-human world, supporting pathways toward resilience, responsibility, and regenerative futures. Mor Keshet is an Integrative Eco-Art Therapist, systems thinker, and founder of TEVEL, a Nature-based healing platform advancing collective resilience in the face of ecological and societal disruption. Her work lives in the intersection of eco and trauma informed psychology, the science of awe, imagination and living systems. Mor's framework origination has appeared in the journal Ecopsychology, Psychology Today and the Biomimicry Institute. Through TEVEL, Mor is building an ecosystem of regenerative care—developing programs, partnerships, and methodologies that position healing as relational, ecological, and culturally responsive. She works with individuals and institutions including The Nature Conservancy, University of Pennsylvania Weitzman School of Design, the American Art Therapy Association, Bard College and Smart City Expo USA. She is the creator of the Climate Emotions Mandala Project, developed in partnership with the Climate Mental Health Network,and holds leadership and teaching roles within the Climate Psychology Alliance – North America and the Climate Emotional Resilience Institute. At the heart of Mor's work is a simple belief: “healing is not a solitary act - it is a shared unfolding.” Connect with Mor via: Email: mor@morkeshet.com  Website: Mor Keshet IG: @morkeshetarttherapist Linked In: Mor Keshet

Welcome to the Pharmacy Podcast Network's special 3-Part series on the coverage of the American Pharmacist Association's Annual Conference event held in Los Angeles, California on March 27-31st. In this series, you'll hear from 4 key social media influencers having a massive impact on Pharmacy Advocacy, innovators exploring the advancing technology and use of AI in Pharmacy, and more! In this episode, we hear from: Jeffrey Gonzales - APhA Board Maurice Shaw, PharmD & Shane Jerominski, PharmD Richard Dang, PharmD Marsha Millonig, Rph Walter Oronsaye, PharmD, MS Thank you to YARAL Pharma for sponsoring this episode!

TWIRx – April 3, 2026 Co-Host: Jesse McCullough On today's episode of This Week in Pharmacy – TWIRx, we welcome special co-host Jesse McCullough for a timely discussion focused on pharmacy innovation, compliance, advocacy, and the future of the profession. We begin with our featured sponsor segment presented by MatchRx, spotlighting two important voices in pharmacy technology and compliance. Johny Kello, CEO of MatchRx, joins the show alongside Riya Cao, CEO of LSPedia, for an important conversation centered on DSCSA readiness and the evolving world of pharmacy compliance. This discussion explores how pharmacies and supply chain stakeholders can better prepare for regulatory expectations, protect patients, and strengthen operational transparency through smarter compliance solutions. In the second half of the episode, we're joined by Scott Brunner, CEO of the Alliance for Pharmacy Compounding (APC), for a recap of the Owner Summit 2026 and a look ahead at what's developing on Capitol Hill. Scott shares insight into the policy landscape impacting pharmacy compounding, the priorities emerging from this year's summit, and what pharmacy owners and industry leaders should be watching as legislative and regulatory conversations continue to evolve. This episode of TWIRx delivers a strong pulse on the profession—from compliance and interoperability to advocacy and the future of compounding pharmacy. Featured Guests: Johny Kello, CEO, MatchRx Riya Cao, CEO, LSPedia Scott Brunner, CEO, Alliance for Pharmacy Compounding (APC) Episode Topics: DSCSA and pharmacy compliance Supply chain visibility and readiness MatchRx and LSPedia collaboration in pharmacy compliance Owner Summit 2026 recap Capitol Hill updates impacting pharmacy compounding The future of compounding and pharmacy advocacy Sponsored by: MatchRx DSCSA Compliance and Compounding Leadership | TWIRx 

On this episode of the PAIN POD, Mark Pain Guy Garofoli chats through the complexities of adjuvant pain medications including antidepressant and other medications from other medical condition treatment plans that overlap in mechanism with pain. Join the discussion right here, right now, on the Pain Pod. Come one, come all, to the Pain Pod!!!

I had an absolute blast sitting down with today's unique guest, chatting on everything from seeking refuge, to exercise, to cancer, to cabbage (stick around to the end to get his amazing raw vegan cabbage recipe, you & your gut will thank me later). Jerzy Gregorek is a four-time World Weightlifting Champion, poet, and co-author of The Happy Body. He helps people reverse aging, regain strength, and restore flexibility through a program that blends mindful exercise, micro progression, and emotional eating intelligence. Jerzy's mission is to show that it's never too late to live a quality life, build vitality, peace of mind, and longevity. Jerzy's journey has been anything but ordinary. After falling into darkness as a teenager, he became an alcoholic from age 15 to 18. Escaping that path shaped his understanding of resilience and personal responsibility. From there, he rebuilt his life - becoming a political exile in the USA, then a world champion weightlifter, and later a mentor, poet, and PhD student. His philosophy - “Hard Choices, Easy Life; Easy Choices, Hard Life” - comes from lived experience and years of guiding people through transformation. What sets Jerzy apart is his ability to integrate physical training, creative expression, and psychological insight into a holistic approach to health and resilience. He emphasizes that emotional intelligence is a crucial element in overcoming life's adversities, and that it can be practiced, cultivated, and mastered.  His three books, titled The Happy Body: Mastering Food, Exercise, and Rest Choices, are designed to help people embrace this path of strength, wisdom, and balance. The poetry book The Happy Body: Food For Your Soul helps with emotional eating. The Happy Body Virtues: Daily Practices for the Modern Stoic helps with emotional eating and self-regulation, while I Got This: The Art of Getting Grit helps with integrating the stories that contribute to building the skill of living a good life. Jerzy has been featured on The Tim Ferriss Show, delivered a Google Talk, and spoken on numerous wellness and longevity podcasts. His work has helped thousands around the globe adopt a sustainable path to strength and wellbeing. Currently, Jerzy is pursuing a PhD in Humanistic Psychology at Saybrook University, focusing on creativity, innovation, and leadership.  Connect with Jerzy via: Email: jerzygregorek@gmail.com  Website: https://thehappybody.com/  X: https://x.com/thehappybody?lang=en  YT: https://www.youtube.com/user/thehappybody  LinkedIn: https://www.linkedin.com/in/jerzy-gregorek-ab87475/ 

This episode is dedicated to the late Dr. Eric Geyer PharmD.  Feautured guest Chuck Melendi Disruptive Dialogue Special report from Bruce Kneeland Sponsored by TJM Labs and interview with Jonathan Adly This episode is sponsored by YARAL Pharma 

This podcast discussion with Paul Shelton zeroes in on a pivotal shift underway in community pharmacy: the expansion of Long-Term Care at Home (LTC@Home) as both a care model and a sustainable business opportunity. Shelton frames LTC@Home not as a reinvention of pharmacy practice, but as a formalization and monetization of services pharmacies are already delivering—medication synchronization, adherence packaging, clinical oversight, caregiver support, and coordination with providers. The core issue isn't capability—it's structure and reimbursement. Many community pharmacies are بالفعل functioning as LTC providers informally, but without the regulatory designation and billing pathways that unlock consistent revenue. A major theme in the conversation is conversion strategy. Shelton discusses how pharmacies can transition into LTC@Home providers by aligning operations with compliance standards, documentation requirements, and payer expectations. This includes setting up the right workflows, leveraging technology for med management and reporting, and ensuring staff are trained to operate within an LTC framework. Importantly, these conversions are not out of reach—they are highly achievable with the right guidance, and they allow pharmacies to immediately begin capturing value for existing services. The financial upside is significant. LTC@Home opens access to enhanced reimbursement models, service-based payments, and stronger payer relationships, especially within Medicare Advantage and managed care environments. Shelton emphasizes that pharmacies are leaving money on the table by not formalizing these services—and that LTC@Home is a direct path to correcting that. Strategically, this model positions community pharmacy at the center of aging-in-place healthcare, one of the fastest-growing segments in the industry. As more patients remain in their homes rather than institutional settings, pharmacies that adapt to LTC@Home will become essential care hubs—supporting not just medication dispensing, but ongoing clinical and logistical care. The takeaway is clear: LTC Pharmacy at Home is not just an opportunity—it's a directional shift for the profession. Pharmacies that move early can differentiate, stabilize revenue, and deepen their role in patient care, while those that delay risk being left behind as the model becomes standard.

Re-introducing Dr A back to host Sex PharmD. Sex Therapy 101 and the 5 Love Languages  

Soda boosting testosterone sounds like the perfect "have your cake and eat it too" health hack, but is there any actual science behind the viral headlines? We're breaking down the mouse study that set the internet on fire and comparing it to massive human data that tells a completely different, and much darker, story for your hormones. A 2022 study found that mice drinking 100% Coke or Pepsi actually had larger testicles and higher testosterone levels. But before you go buy a 12-pack, you need to realize that men are not mice, and what works in a 15-day rodent trial often fails miserably in humans. In fact, when we look at data from thousands of men, the reality is that high sugary drink consumption is linked to more than double the risk of clinically low testosterone. We dive into why the sugar in your soda fuels obesity and insulin resistance—two of the biggest "testosterone killers" on the planet. This show is intended for educational and informational purpose Website: https://RatedRxMedia.com YouTube: https://www.youtube.com/@RatedRxMedia Instagram: https://www.instagram.com/ratedrxmedia/ TikTok: https://www.tiktok.com/@ratedrxmedia/ Facebook: https://www.facebook.com/people/Rated-Rx/61574813907982/ Spotify: https://open.spotify.com/show/7KATtG1c3HwwYpVMtRuNub Apple Podcasts: https://podcasts.apple.com/us/podcast/rated-rx/id1804181016

In this industry-focused, conversational interview, Pharmacy Podcast Network Host Todd Eury speaks with Stephen Beckman, CEO of YARAL Pharma. The discussion explores YARAL Pharma's commitment to continuity of supply, how consistent on-time delivery supports pharmacy operations, and the company's philosophy of “Doing Things Differently” — redefining what it means to be a trusted generics partner.  

A website is your brand identifier and how people find out about your business. We discuss why just social media isn't enough, but how it can work in tangent with a website. And also the benefits of working with a vendor that works with you in building a custom site and gives you access for ongoing management if you choose. 

Welcome to Tech Trends Pharmacy Podcast sponsored by PrimeRx, today's a special epsiode features the original "Pharmacy Badass" CEO of DiversifyRx, and founder of the Pharmacy Profit Summit, Dr. Lisa Faast. PAUSE, Get ready for a discussion on a blueprint on generating new non-PBM revenues and a sneak peak of "Pharmacy Profit Summit 2026 in Dallas, coming March 28 through 29th in Dallas.

Welcome to this special three-part press coverage series from the Pharmacy Podcast Network, recorded on location at the Pennsylvania Pharmacists Association Annual Conference, held February 20th through the 22nd at the Hilton Harrisburg. This series is proudly sponsored by Value Drug Company and the Pennsylvania Pharmacists Care Network — PPCN — as they celebrate their 10th anniversary of advancing pharmacist-led patient care across the Commonwealth.   In this episode we hear from: Nicole Mannella Hasson - Value Drug Kyle McCormick PharmD & Brandon Antinopoulos, PharmD Kerry Trueman - AlignRx Nishaminy (Nish) Kasbekar, PharmD, BSPharm, FASHP - Penn Medicine  Mark Pilkington, BS Pharm, MS Justin Leonard - PrimeRx Michael D. Hogue, PharmD, FAPhA Victoria Elliot - CEO PPA

This week we look at a somewhat confusing, possibly problematic FDA statement, as well as the anti-compounding bills popping up across the country. Our Deep Dive this week is a hot topic: AI in pharmacies — how it's being used successfully, but also how you can use it to streamline your workflow and, yes, even increase your bottom line. Our expert will tell you what to look for, and what easy pitfall you need to avoid. Links from the podcast: The troublesome FDA statement: https://fllw.me/4utzQIw APC's Snapshot of Pharmacy Compounding: https://a4pc.org/snapshot Read more about the 2002 Supreme Court case "Thompson v. Western States Medical Center": https://www.oyez.org/cases/2001/01-344 TJM Labs: https://tjmlabs.com Join APC: https://a4pc.org/join

Welcome to this special three-part press coverage series from the Pharmacy Podcast Network, recorded on location at the Pennsylvania Pharmacists Association Annual Conference, held February 20th through the 22nd at the Hilton Harrisburg. This series is proudly sponsored by Value Drug Company and the Pennsylvania Pharmacists Care Network — PPCN — as they celebrate their 10th anniversary of advancing pharmacist-led patient care across the Commonwealth.   In this episode we hear from: Darryle Tillman, RPh & John DeJames Jonathan Ference PharmD Jake Reckenbauher Dr Gavin Merin & Angela York - Value Drug Tom DePietro

On this week's This Week in Pharmacy (TWIRx), we explore how innovation, technology, and emerging therapies are reshaping pharmacy practice. From the growing influence of AI in medical information research, to the next generation of pharmacy management systems, and the expanding role of cell and gene therapies, this episode brings together industry leaders to discuss what's next for pharmacy. Special thanks to this week's sponsors Cardinal Health, Independent Pharmacy Cooperative (IPC), and Nested Knowledge for supporting the podcast. Segment 1 – AI & the Future of Medical Information with Nested Knowledge Nested Knowledge returns to TWIRx as we welcome back Keith Kallmes, Co-Founder of Nested Knowledge, for an update on how artificial intelligence is transforming the way healthcare professionals access and interpret medical information. Keith explains how AI-powered tools are improving evidence synthesis, systematic literature reviews, and clinical decision support, helping researchers and clinicians navigate the growing volume of medical literature while enabling faster, more reliable insights. Segment 2 – The Evolution of Pharmacy Management Systems with Outcomes Next, we're joined by Lou Ann Myers from Outcomes to discuss how pharmacy management systems are evolving beyond traditional dispensing. Modern pharmacies require integrated technology connecting billing, treatment planning, clinical tracking, inventory management, and revenue-generating services. Lou Ann shares why these systems must support both clinical services and business sustainability as pharmacies expand into value-based care and new service models. Segment 3 – Emerging Therapies with Cardinal Health In our final segment, we welcome Dr. Fran Gregory, PharmD, Vice President of Emerging Therapies (Cell & Gene, Biosimilars) at Cardinal Health, to discuss one of the most transformative areas in healthcare. Dr. Gregory explores the growing impact of cell and gene therapies and biosimilars, and what these innovations mean for pharmacists, health systems, and specialty pharmacy providers as the industry prepares for new challenges in distribution, access, and reimbursement. About TWIRx (This Week in Pharmacy) TWIRx is the flagship news and commentary podcast from the Pharmacy Podcast Network, delivering weekly insights on the business, technology, and policy shaping the pharmacy profession.

In this inspiring episode of CPhT Connect, host Mike Johnston, CPhT-Adv, sits down with Ellaine Sisomphou-Ramos, a nationally certified pharmacy technician whose career is a masterclass in professional growth and self-advocacy. Originally trained as a nurse in the Philippines, "Ella" shares her remarkable journey of transitioning to the U.S. pharmacy landscape, moving from high-volume retail to a specialized role in outpatient infusion and specialty pharmacy. Her dedication to clinical excellence recently earned her a nomination as one of the Top 50 Most Influential Leaders in The Pharmacy 50 Awards by Pharmacy Podcast Network, where she ranked in the top 45—a powerful testament to the impact a technician can have on the entire profession.

Dental care during pregnancy is often overlooked in routine prenatal counseling, yet hormonal changes, frequent vomiting, dehydration, and acid exposure can significantly impact oral health in pregnancy. In this episode of the MaternalRx Podcast, host Dr. Danielle Plummer, PharmD speaks with Dr. Michael Duboff, DMD, about the critical importance of dental care during pregnancy and how pharmacists and healthcare providers can help prevent long-term complications. From enamel erosion caused by hyperemesis gravidarum to pregnancy gingivitis and periodontal disease, this conversation explores what happens inside the mouth during pregnancy, when tooth damage becomes irreversible, and what practical steps patients and healthcare providers can take to protect oral health. Dr. Duboff also addresses common misconceptions about the safety of dental treatment during pregnancy, including fluoride use, dental X-rays, anesthetics, and the importance of preventive dental care. The episode also highlights insurance and access issues, including how some insurance plans and Medicaid programs may expand dental coverage during pregnancy, an important opportunity for patients to receive needed care. This episode emphasizes the critical role pharmacists can play in maternal health education, early identification of oral health risks, and patient counseling. You'll Learn: • How repeated gastric acid exposure from vomiting can weaken tooth enamel during pregnancy • Why brushing immediately after vomiting can worsen enamel erosion • Safe oral care strategies for pregnant patients with severe nausea or hyperemesis gravidarum • What pregnancy gingivitis is and why hormonal changes increase gum inflammation and bleeding • How fluoride varnish and high-fluoride toothpaste help protect enamel during pregnancy • Why dental cleanings every 3 months may benefit pregnant patients • The link between periodontal disease and adverse pregnancy outcomes, including preterm birth and low birth weight • Why dental treatment—including X-rays and local anesthetics—is generally safe during pregnancy • Restorative treatment options for enamel erosion and tooth decay, including fillings, crowns, and bonding • How insurance coverage and Medicaid policies may provide expanded dental benefits during pregnancy • The important role pharmacists can play in oral health counseling for pregnant patients Key Clinical Takeaways 1. Gastric Acid Damages Tooth Enamel Frequent vomiting exposes teeth to stomach acid, which erodes enamel and exposes the underlying dentin, increasing the risk of decay and sensitivity. 2. Do NOT Brush Immediately After Vomiting Brushing immediately after vomiting can scrub away weakened enamel. Instead: Rinse with water or a baking soda solution Wait about 30 minutes before brushing 3. Pregnancy Increases Risk of Gingivitis Hormonal changes during pregnancy increase gum inflammation and bleeding, making good oral hygiene and professional cleanings even more important. 4. Dental Care During Pregnancy Is Safe Preventive care and many dental treatments—including dental X-rays with shielding and local anesthetics—are considered safe, particularly during the second trimester. 5. Preventive Care Is Essential Regular dental visits, fluoride treatments, and proper oral hygiene can help prevent irreversible enamel damage and periodontal disease. 6. Insurance Coverage May Improve During Pregnancy Some insurance plans and Medicaid programs expand dental coverage for pregnant patients, providing an important opportunity to receive preventive care and necessary dental treatment. Practical Counseling Tips for Pharmacists Pharmacists can support pregnant patients by recommending: • Rinsing with water or baking soda solution after vomiting • Waiting 30 minutes before brushing teeth • Using fluoride toothpaste or prescription high-fluoride toothpaste if appropriate • Maintaining hydration whenever possible • Scheduling regular dental visits during pregnancy • Seeking evaluation for bleeding gums, tooth sensitivity, or oral pain Because pharmacists are often the most accessible healthcare professionals, they play an important role in identifying oral health risks early and encouraging patients to seek dental care. Connect With Our Guests Dr. Michael Duboff, DMD Practice: AXIS Dental – Las Vegas Email: SmileDesignersLV@yahoo.com Dr. Danielle Plummer, PharmD Website: www.Obstet-Rx.com LinkedIn: https://www.linkedin.com/in/daniellerplummer/

Welcome to PPN – The Precision Medicine Pharmacist, the podcast where science, innovation, and collaboration are redefining patient care. We are kicking off a special two-part series titled Precision Psychiatry in Practice – A Pharmacist–Physician Collaboration. In this series, we explore how precision medicine is reshaping mental health treatment — and what becomes possible when pharmacists and psychiatrists work together with shared clinical goals. Today's episode, The New Frontier: How Pharmacists and Psychiatrists Are Teaming Up for Precision Mental Health, focuses on how this collaboration began — the challenges that inspired it, the early conversations that shaped it, and the practical steps taken to bring pharmacogenomics into psychiatric care. Joining us is Dr. Saba Arshad, clinical pharmacist, founder of Med DNA Health, and a strong advocate for integrating pharmacogenomic insight into mental health treatment. We will also hear from Dr. Afshan Khan, psychiatrist and clinical partner in this model of care, as we explore how their professional paths aligned to create something new. In this first episode, we will lay the foundation — examining the “why” behind precision psychiatry and the systems that had to evolve to support it. Then, in part two, Dr. Khan will join us more extensively as we move from framework to real-world impact, sharing patient cases, clinical outcomes, and lessons learned from implementing precision medicine in practice.

Welcome back to season 9! We're kicking it off with my first powerhouse guest, whose mission is to bring clarity, safety, and evidence-based understanding to hyperbaric oxygen therapy and integrative wellness. There is a growing wave of interest in longevity and recovery therapies, but also a lot of confusion and misinformation. She breaks down the science (and safety) of one of the most powerful, foundational tools we have for reducing inflammation, accelerating healing, and supporting long-term health.  Nicole Garrett is the CEO of Under Pressure Hyperbarics, a premier hyperbaric oxygen therapy center in Beverly Hills recognized for its clinical-grade safety standards and results-driven approach to wellness. With nearly two decades of experience in hyperbaric medicine, her career began as a commercial diver and dive medic, where she first learned the life-saving applications of pressure and oxygen in extreme environments. Since then, Nicole has helped open and operate HBOT centers across the country and has become a trusted leader in the field. Her work bridges the gap between medical-grade hyperbaric therapy and modern holistic wellness, offering patients a safe and effective path to healing, recovery, and long-term vitality. Nicole is especially passionate about educating clinicians, patients, and the wellness community on the science, indications, and proper protocols behind hyperbaric therapy. Today, she leads a multidisciplinary team at Under Pressure Hyperbarics that supports surgical recovery, sports performance, chronic inflammation, and overall health optimization using hospital-grade chambers and evidence-aligned treatment plans. Connect with Nicole via: Email: nicole@underpressure.com  Website: Under Pressure Hyperbarics FB: Under Pressure Hyperbarics IG: @underpressurehyperbarics Linked In: Under Pressure Hyperbarics

Welcome to this special three-part press coverage series from the Pharmacy Podcast Network, recorded on location at the Pennsylvania Pharmacists Association Annual Conference, held February 20th through the 22nd at the Hilton Harrisburg. This series is proudly sponsored by Value Drug Company and the Pennsylvania Pharmacists Care Network — PPCN — as they celebrate their 10th anniversary of advancing pharmacist-led patient care across the Commonwealth.   In this episode we hear from: Margie Lydon - Value Drug Company Darren Mensch, PharmD, BCPS, BCACP Hayleigh Monroe - P4 Pharmacy Student Mayank (Dr. Mak) Amin, PharmD, RPh, MBA  Todd Laser - Value Drug Company Jonathan Adly - TJM Labs  Jennifer (Pekich) Urso  

Welcome to another episode of TWIRx – This Week in Pharmacy, where we break down the most important developments impacting the pharmacy profession. This week's show features leaders from across community pharmacy, health systems, healthcare advocacy, and international patient engagement. From PBM reform to patient-centered care and health system growth in Western Pennsylvania, this episode brings together voices shaping the future of pharmacy. Sponsored by Sykes & Company, P.A. Accounting, tax strategy, and advisory services dedicated exclusively to independent pharmacy operators. Segment 1 Austin Murray Communications and Marketing Director – Sykes & Company, P.A. We kick off TWIRx with Austin Murray from Sykes & Company, discussing the NCPA Consumer Marketing Campaign designed to educate the public about the value of community pharmacies. Austin shares insights on: • The importance of telling the community pharmacy story directly to consumers • Why independent pharmacies remain essential healthcare access points • The evolving state of independent pharmacy nationwide • Continued momentum around PBM Reform • Strategic accounting and tax advantages pharmacy operators should understand in today's challenging reimbursement environment Austin also explains how pharmacy-focused accounting firms like Sykes & Company help owners navigate reimbursement pressure, tax planning, and business strategy. Segment 2 Mark Duman Pharmacy 50 Award Winner – United Kingdom International healthcare thought leader Mark Duman joins TWIRx to discuss one of the most important principles in healthcare transformation: The patient must come first. Mark shares his perspective on: • Why healthcare systems must remain patient-centered • How pharmacy can lead the way in improving patient outcomes • Lessons learned from patient engagement initiatives in the UK healthcare system • Why meaningful healthcare innovation always begins by focusing on the patient experience Mark emphasizes that when healthcare professionals keep the patient as the constant focus, better pharmacy care and stronger health systems follow. Segment 3 Dr. Laura Mark, PharmD Vice President of Pharmacy – Allegheny Health Network Next, we welcome Dr. Laura Mark, Vice President of Pharmacy at Allegheny Health Network (AHN), who shares exciting news about new pharmacy operations facilities recently built in Butler County, Pennsylvania. Todd and Laura also reflect on their shared roots growing up in Butler County, while discussing how AHN is investing in the future of pharmacy. Topics include: • The new pharmacy operations infrastructure in Western Pennsylvania • How AHN is expanding pharmacy services across the Greater Pittsburgh region • The role of health system pharmacy in improving access to care • Strategic positioning for future healthcare growth and integration AHN continues to strengthen its pharmacy operations as a key component of coordinated patient care throughout the region. Segment 4 Eric Pusey Independent Pharmacy Owner – Pennsylvania Closing out this week's episode, pharmacy owner Eric Pusey joins TWIRx to discuss the latest updates on PBM Reform in Pennsylvania. In 2024, Pennsylvania enacted Act 77, a landmark law aimed at increasing oversight and fairness in pharmacy benefit management. Eric explains how the law: • Grants new regulatory authority to the Pennsylvania Insurance Department • Restricts PBM patient steering to pharmacies owned or affiliated with benefit managers • Improves transparency requirements for PBM operations • Establishes payment protections intended to level the playing field for community pharmacies Patient steering practices have long limited competition and reduced patient choice. Eric shares why these reforms represent an important step toward protecting both patients and independent pharmacy providers across the Commonwealth. Listen & Subscribe Stay informed on the business, policy, and innovation shaping the pharmacy profession. Follow TWIRx – This Week in Pharmacy on the Pharmacy Podcast Network, featuring conversations with the leaders and advocates advancing pharmacy practice.

In this episode, listeners get to know the leadership of the California Pharmacists Association (CPhA), exploring their professional journeys, personal backgrounds, and the experiences that shaped their commitment to advancing the pharmacy profession. Susan Bonilla, CEO of the California Pharmacists Association, joins Dr. Sean Kim, PharmD, Vice President of Practice & Professional Development at CPhA, to discuss California's progress in pharmacy benefit manager (PBM) reform. As the largest state in the nation, California continues to play a significant role in shaping policies that strengthen patient access to pharmacy care and improve transparency within the prescription drug supply chain. Bonilla and Kim share insights into the reforms California has achieved, the legislative and regulatory priorities currently underway, and how these efforts may influence PBM reform conversations across the country. The PBM Reform Podcast is sponsored by the American Pharmacy Cooperative, Inc. (APCI). APCI's sponsorship supports the production of this program but does not imply affiliation with the individual guests, nor endorsement of the views, opinions, or insights shared by podcast hosts or guests. APCI does not endorse any statements or content discussed on the PBM Reform Podcast or across the Pharmacy Podcast Network. Please reach out to the APCI Communication's team for additional information. 

In this edition of Essential, we look at two major issues facing pharmacy compounding. First is a state-by-state effort by pharma companies to pass laws restricting compounding, and second is a cryptic statement from the FDA about  possible limitations on compounding with GLP-1 ingredients. They're both Very Big Deals for pharmacists across the country. Links FDA statement on GLP-1 drugs: https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs … and APC's response: https://a4pc.org/news/apc-responds-to-fdas-glp-1-statement  Stay up to date on our state Compounding Defense Initiative: compounding.com  Join APC today: https://a4pc.org/membership  Find us on social: LinkedIn: https://www.linkedin.com/company/a4pcrx/ Facebook: https://www.facebook.com/a4pcrx/ Instagram: https://www.instagram.com/a4pcrx/

In this episode of Framework Focus, Dr. Dae Lee breaks down the regulatory and reimbursement shifts reshaping long-term care (LTC) pharmacy. With the Inflation Reduction Act (IRA) moving from policy theory to operational reality, Medicare's Maximum Fair Price (MFP) program, Part D redesign, and inflation rebate enforcement are now active forces that LTC operators must navigate. This conversation moves beyond headlines and into real-world implications: cash flow risk, administrative burden, contracting exposure, and strategic readiness for closed-door and combo LTC pharmacies. Key Discussion Points Medicare Drug Price Negotiation Is Now Operational  The IRA authorizes Medicare to negotiate prices for certain high-spend Part D drugs, with the first 10 Maximum Fair Prices (MFPs) effective January 1, 2026. This marks a structural shift in federal drug pricing and directly impacts LTC dispensing economics. Maximum Fair Price and LTC Reimbursement Compression  MFP caps reimbursement on selected drugs, creating potential margin compression if acquisition costs and payment timing are misaligned. For LTC pharmacies operating on tight spreads and high-volume chronic utilization, even small deltas can materially affect profitability. Medicare Transaction Facilitator (MTF) and Payment Timing Risk  The MTF system introduces new payment mechanics between manufacturers, plans, and pharmacies. LTC pharmacies must understand how effectuation and reconciliation work, particularly if payment timing differs from traditional Part D adjudication flows. Cash flow modeling becomes essential. Administrative Complexity and Claims Reconciliation  Identifying which NDCs are subject to MFP, managing claim reversals, handling price disputes, and monitoring plan-level compliance will increase administrative workload. LTC pharmacies will need structured internal workflows to prevent reimbursement leakage. Dispensing Fees and the LTC Service Intensity Problem  Unlike retail, LTC pharmacy includes compliance packaging, emergency kits, cycle fills, consultant pharmacist oversight, and regulatory documentation. Current IRA implementation does not automatically adjust dispensing or supply fees to reflect this complexity, raising sustainability concerns. Congressional Efforts to Stabilize LTC Pharmacy  Legislative proposals such as the Preserving Patient Access to LTC Pharmacies Act aim to create supply fee protections tied to MFP drugs. The episode explores whether policy corrections are likely — and how quickly DC can realistically respond. Expansion of Negotiated Drug Lists  The initial 10 negotiated drugs are only the beginning. Additional rounds of negotiation are underway, expanding exposure across more therapeutic classes. LTC pharmacies must treat MFP as a growing structural feature — not a limited pilot. Part D Redesign and the $2,100 Out-of-Pocket Cap  Beginning in 2026, the redesigned Part D benefit changes liability distribution among plans, manufacturers, and CMS. The new out-of-pocket cap alters plan incentives and may lead to tighter utilization management, formulary shifts, and network recalibration — all of which LTC pharmacies must monitor closely. Inflation Rebates and Market Distortion  The IRA's inflation rebate provisions penalize manufacturers for price increases above inflation benchmarks. While not directly adjudicated at the pharmacy counter, these provisions influence manufacturer pricing strategy, launch pricing behavior, and downstream PBM negotiations — indirectly affecting LTC acquisition costs. Strategic Readiness as a Competitive Advantage  The episode concludes with practical recommendations:  • Conduct an MFP exposure audit across top-dispensed NDCs  • Reassess PBM contracts and network participation clauses  • Model cash flow under delayed reimbursement scenarios  • Educate facility partners on regulatory changes  • Build internal compliance tracking specific to negotiated drugs Why This Matters Now For LTC pharmacies, this is not simply a policy conversation — it is a structural shift in reimbursement architecture. As federal oversight expands and pricing authority evolves, operational precision and legal literacy will define which organizations adapt successfully. About our guest:  Dr. Dae Lee, Pharm.D, Esq., CPBS  Shareholder - Buchanan Ingersoll & Rooney PC  Email: dae.lee@bipc.com  Dae Y. Lee is a pharmacist-attorney and Certified Pharmacy Benefits Specialist™ (CPBS™) who represents pharmacies, healthcare stakeholders, and plan sponsors in high-stakes disputes and regulatory matters involving Pharmacy Benefit Managers (PBMs) and government payors. Drawing on his dual training as a pharmacist and attorney, Dae focuses his practice on defending clients in audits, investigations, enforcement actions and complex reimbursement and compliance matters. Dae routinely represents pharmacies nationwide in PBM and payor audits, including Fraud, Waste and Abuse (FWA) investigations, extrapolation disputes, overpayment recoupments, credentialing denials, network suspensions and terminations. He advises pharmacies on compliance with applicable state pharmacy fair audit laws, PBM provider manuals, and reimbursement standards, with the goal of minimizing financial exposure while preserving network participation and business continuity.

On this episode of This Week in Pharmacy, we spotlight two major conversations shaping the future of pharmacy practice in 2026. First, we welcome Dr. Lisa Faast, PharmD, founder of DiversifyRx, to discuss the Pharmacy Profit Summit 2026 and how independent pharmacies can strengthen margins, diversify revenue streams, and build sustainable growth models in today's reimbursement environment. Then, we turn to Rare Disease Day 2026 with Richard Ferris, PharmD, Chief Commercial & Clinical Officer at PantherRx, to discuss specialty pharmacy leadership, pharmacist impact, and new patient feedback data revealing communication gaps in rare disease care. Segment 1: Pharmacy Profit Summit 2026 Guest: Dr. Lisa Faast, PharmD | Founder, DiversifyRx Dr. Faast joins us to break down the vision behind Pharmacy Profit Summit 2026 — an event designed to equip pharmacy owners with practical strategies to increase profitability while maintaining clinical excellence. Key Topics Covered: • Why independent pharmacies must move beyond traditional dispensing revenue  • Diversification strategies including niche services and high-value offerings  • Real-world financial benchmarks pharmacy owners should track  • How mindset, leadership, and data discipline drive sustainable profitability  • The importance of collaboration and shared intelligence among pharmacy entrepreneurs The Pharmacy Profit Summit is not just about revenue — it's about equipping pharmacy owners to compete intelligently in a rapidly consolidating healthcare market. Segment 2: Rare Disease Day 2026 Guest: Richard Ferris, PharmD | PantherRx Rare Pharmacy In recognition of Rare Disease Day 2026, we are honored to welcome Richard Ferris, PharmD, to discuss the critical role pharmacists play in specialty pharmacy and rare disease care. PantherRx recently released survey findings examining patient and caregiver experiences within rare disease treatment journeys. Key Study Highlights: • 90% of patients and caregivers report delays due to communication gaps  • 68% report waiting for updates from providers, pharmacies, or insurers  • 90% say they manage the care process themselves  • 72% desire a dedicated care coordinator  • 73% agree it is unclear who is responsible for coordinating rare disease care Despite advances in specialty therapeutics, patients are still asking for the fundamentals: clear communication, coordinated care, and personalized support. Richard discusses: • The growing importance of specialty pharmacists as care coordinators  • Why rare disease patients often feel burdened by system fragmentation  • How specialty pharmacy can close communication gaps  • The need for pharmacist-led continuity in complex therapy management Rare Disease Day reminds us that specialty pharmacy is not only about high-cost medications — it is about human connection, long-term coordination, and advocacy for patients navigating some of the most complex clinical journeys in healthcare.  From business sustainability to patient-centered specialty care, this episode reinforces two realities: Pharmacy must remain financially strong to survive. Pharmacists must remain clinically present to lead. As the profession evolves, profitability and patient advocacy are not opposing forces — they are interdependent pillars of pharmacy's future. Listen now and join the conversation shaping Pharmacy in 2026.

Many pharmacy owners invest in expensive technology but fail to fully utilize the system's secondary and valuable features. This is a costly mistake!  It leaves significant operational efficiencies and profit opportunities unrealized. This program also invites managers to carefully review their tech vendor invoices to ensure new charges have not been added or that fees have not been quietly increased for features in their software agreements. Kevin Minassian, President of DataScan, notes his company provides a wide range of profit-enhancing services at no additional cost while competitors often add additional fees. Visit www.datascanpharmacy.com for more information.  

 “Thug Drugs: Policy” THUG DRUGS! With a name like that, it has to be good! Even better than Smuckers (Age old ad slogan for jelly/jam)!  In this episode of the Pain Pod, we're going to dive into Thug Drug Policies, here in our country, and beyond. Come one, come all, to the Pain Pod!!! www.painguy.us  

Welcome back to the Pediatric Pharmacist Review Podcast. Today's Pharmacist Spotlight features Brian Seyboth, a pediatric hematology/oncology pharmacist and the first full-time pharmacist at Perfecting Peds. In this episode, Brian shares a powerful patient care win that shaped his career and highlights why pediatric oncology pharmacy is both highly technical and deeply personal. We discuss how pharmacists optimize complex medication regimens, support families during difficult diagnoses, and improve outcomes through collaborative decision-making. Brian also reflects on mentoring residents, expanding pharmacist integration into pediatric care teams, and adapting clinical pharmacy services into a virtual environment. Whether you're a student, resident, or practicing clinician, this conversation shows how pharmacists can transform pediatric care through expertise and compassion. Let's get started.

How Kroger does PBM and the future of community pharmacy is clinical encounters.